Drug Approval | March 05, 2025
Unichem Laboratories receives 4 observations from USFDA for Pithampur API facility
The company will provide the necessary response on these observations to USFDA within stipulated 15 days
The company will provide the necessary response on these observations to USFDA within stipulated 15 days
Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction
Zydus will carry out early-stage development, animal immunogenicity studies and regulatory preclinical toxicology studies for this combination vaccine
Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations
The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
The launch follows the approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K.
The PIPE offering consists of 36,190,476 units
Standalone profit from operations for Q4-2024 were Rs. 108 crore
This will lead to the consolidation and optimization of the company's operations related to the manufacturing of ampoules and vials
Subscribe To Our Newsletter & Stay Updated
